ArticleScientific reports2025
Graph feature selection for enhancing radiomic stability and reproducibility across multiple institutions in head and neck cancer.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Impact of Radiomics Parameters and Clinical Integration on Prognostication in Head and Neck Squamous Cell Carcinoma: A Multicenter Study.Life (Basel, Switzerland) · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Radiomic biomarkers offer promise for precision oncology. However, their clinical utility is limited by variability from differing imaging protocols and the high dimensionality of radiomics data. Feature selection is key for better interpretability, accuracy, and efficiency, yet traditional methods lack stability and reproducibility. We investigate a Graph-Based Feature Selection (Graph-FS) approach that models feature interdependencies to identify stable radiomic signatures for head and neck squamous cell carcinoma (HNSCC) across institutions. We retrospectively analyzed 1,648 radiomic features extracted from the gross tumor volumes of 752 HNSCC patients from three institutions. After standard preprocessing and applying 36 radiomics parameter configurations to simulate variability, we compared Graph-FS with established methods: Boruta, Lasso, Recursive Feature Elimination (RFE), and Minimum Redundancy Maximum Relevance (mRMR). We evaluated feature selection stability and reproducibility using Pearson correlation, the Jaccard Index (JI), and the Dice-Sorensen Index (DSI) and assessed ranking consistency with Kendall's Coefficient of Concordance (W). Graph-FS achieved higher stability (JI = 0.46, DSI = 0.62, OP = 45.8%) versus baseline methods with JI of 0.005 (Boruta), 0.010 (Lasso), 0.006 (RFE) and 0.014 (mRMR). These results demonstrate that Graph-FS enhances feature stability, reproducibility, and predictive performance. This method could facilitate integration into AI-driven radiomics workflows for reliable, multi-center biomarker discovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.